A detailed history of Natixis Advisors, L.P. transactions in Glaukos Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 37,738 shares of GKOS stock, worth $5.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,738
Previous 37,297 1.18%
Holding current value
$5.69 Million
Previous $4.41 Million 11.4%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$113.62 - $135.39 $50,106 - $59,706
441 Added 1.18%
37,738 $4.92 Million
Q2 2024

Aug 01, 2024

BUY
$89.48 - $118.35 $372,057 - $492,099
4,158 Added 12.55%
37,297 $4.41 Million
Q1 2024

Apr 25, 2024

SELL
$76.4 - $96.33 $441,668 - $556,883
-5,781 Reduced 14.85%
33,139 $3.13 Million
Q4 2023

Feb 06, 2024

BUY
$59.53 - $85.11 $294,137 - $420,528
4,941 Added 14.54%
38,920 $3.09 Million
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $89,860 - $102,658
1,298 Added 3.97%
33,979 $2.56 Million
Q2 2023

Aug 15, 2023

BUY
$45.44 - $71.21 $669,240 - $1.05 Million
14,728 Added 82.04%
32,681 $2.33 Million
Q1 2023

May 11, 2023

BUY
$43.88 - $52.48 $326,818 - $390,871
7,448 Added 70.9%
17,953 $899,000
Q4 2022

Jan 27, 2023

SELL
$40.82 - $57.75 $346,357 - $490,008
-8,485 Reduced 44.68%
10,505 $459,000
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $376,499 - $470,142
8,038 Added 73.39%
18,990 $1.01 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $24,402 - $44,639
-700 Reduced 6.01%
10,952 $497,000
Q1 2022

May 12, 2022

BUY
$44.33 - $57.82 $516,533 - $673,718
11,652 New
11,652 $674,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.